Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.20.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Cash flows from operating activities:    
Net loss from continuing operations $ (9,697,922) $ (37,865,236)
Adjustments to reconcile net loss to net cash (used in) provided by operations:    
Depreciation and amortization 399,377 609,818
Stock-based compensation 25,950
Amortization of debt discount 108,958 6,386,305
Modification of warrants 9,464,991
Gain on extinguishment of debt (389,864)
Gain from legal settlements (1,096,613)
Other income from federal government relief funds (8,020,969)
Penalty for non-payment of debentures 5,710,440
Change in fair value of derivative instruments (105,076)
Loss on disposal of property and equipment 87,293
Loss on sale of accounts receivables under sales agreements 591,563 1,361,053
Bargain purchase gain for hospital and medical center (250,000)
Loss from discontinued operations (164,293) (1,266,764)
Changes in operating assets and liabilities:    
Accounts receivable 1,241,398 (3,564,790)
Inventory (76,065) 1,174
Prepaid expenses and other current assets (224,733) 81,751
Security deposits (56,482) (34,659)
Accounts payable and checks issued in excess of bank balance (1,065,570) 4,974,361
Accrued expenses 5,563,232 (371,438)
Income tax assets and liabilities (522,885) (45,000)
Net cash used in operating activities of continuing operations (13,323,575) (14,676,968)
Net cash (used in) provided by operating activities of discontinued operations (100,685) 302,755
Net cash used in operating activities (13,424,260) (14,374,213)
Cash flows from investing activities:    
Purchase of hospital and medical center (658,537)
Purchase of property and equipment (370,890) (50,801)
Net cash used in investing activities of continuing operations (370,890) (709,338)
Net cash from investing activities of discontinued operations
Net cash used in investing activities (370,890) (709,338)
Cash flows from financing activities:    
Proceeds from issuance of related party notes payable and advances 5,809,553 16,478,104
Payments on related party notes payable and advances (4,187,387) (2,310,000)
Proceeds from issuance of debentures 3,845,000
Proceeds from notes payable 1,198,835 1,500,000
Payments on notes payable (1,522,748) (5,005,794)
Payments on debentures (920,000)
Proceeds from accounts receivable sales agreements 841,700 2,650,000
Payments on right-to-use liabilities (98,374) (41,953)
Proceeds from Paycheck Protection Program notes payable 2,264,201
HHS Provider Relief Funds 12,542,691
Cash paid for fractional shares in connection with reverse stock split (684)
Payments of accounts receivable under sales agreements (1,540,929) (1,782,614)
Payments on finance lease obligations (200,709) (143,930)
Net cash provided by financing activities of continuing operations 14,156,149 15,188,813
Net cash used in financing activities of discontinued operations (157,589)
Net cash provided by financing activities 13,998,560 15,188,813
Net increase in cash 203,410 105,262
Cash at beginning of period 16,933 2,209
Cash at end of period $ 220,343 $ 107,471